MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-12-2024
Natera ROE Ratio 2011-2026 | NTRA
Annual ROE Ratio Natera
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -77.62 | -72.2 | -47.25 | -44.79 | -398.46 | 1314.5 | -89.94 | -38.03 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1314.5 | -398.46 | 68.28 |
Quarterly ROE Ratio Natera
| 2024-Q3 | 2023-Q4 | 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -31.39 | -13.9 | -39.45 | -51.11 | -71.04 | -65.42 | -104.21 | -75.86 | -87.86 | -79.92 | -53.4 | -31.53 | -44.16 | -40.46 | -39.83 | -44.79 | -131.17 | -214.95 | -308.49 | -398.46 | -485.23 | -502.78 | -511.97 | -541.48 | -382.11 | -296.92 | -204.31 | -80.74 | -64.48 | -49.59 | -38.49 | -35.75 | -26.34 | -18.97 | -8.02 | -2.61 | -1.87 | 0.3 | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.3 | -541.48 | -136.28 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Anixa Biosciences
ANIX
|
-72.07 | $ 3.03 | -2.26 % | $ 98.3 K |  USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 39.83 | 1.7 % | $ 1.11 B | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Brainsway Ltd.
BWAY
|
-27.43 | $ 23.52 | -2.2 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 34.0 | 0.68 % | $ 366 M |  China |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-35.99 | $ 102.43 | 0.13 % | $ 19 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 26.13 | -0.44 % | $ 790 M | USA |
 |
BioNano Genomics
BNGO
|
-316.66 | $ 1.3 | -11.56 % | $ 1.65 M | USA |
 |
Guardant Health
GH
|
312.48 | $ 111.99 | 1.37 % | $ 13.7 B | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
-41.08 | - | - | $ 79.8 M | USA |
 |
Danaher Corporation
DHR
|
7.87 | $ 218.32 | -0.59 % | $ 160 B | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
28.72 | $ 66.61 | -0.1 % | $ 4.61 B | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
DexCom
DXCM
|
26.18 | $ 73.22 | -1.05 % | $ 28.3 B | USA |
 |
NeoGenomics
NEO
|
-8.72 | $ 11.91 | -3.95 % | $ 1.51 B | USA |
 |
CareDx, Inc
CDNA
|
-72.81 | $ 20.33 | -2.26 % | $ 1.09 B | USA |
 |
Celcuity
CELC
|
-96.68 | $ 108.09 | -3.59 % | $ 4.26 B | USA |
 |
DarioHealth Corp.
DRIO
|
-102.21 | $ 10.14 | -1.55 % | $ 288 M | Israel |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Personalis
PSNL
|
-40.05 | $ 9.27 | -7.02 % | $ 549 M | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 144.04 | -3.77 % | $ 22.9 B | USA |
 |
QIAGEN N.V.
QGEN
|
2.34 | - | - | $ 10.6 B |  Niderland |
 |
IQVIA Holdings
IQV
|
22.63 | $ 229.24 | -2.71 % | $ 41.6 B | USA |
 |
Charles River Laboratories International
CRL
|
0.64 | $ 208.45 | -1.53 % | $ 10.7 B | USA |
 |
Thermo Fisher Scientific
TMO
|
12.78 | $ 575.61 | -2.79 % | $ 220 B | USA |
 |
Trinity Biotech plc
TRIB
|
287.88 | $ 0.81 | -7.96 % | $ 61.9 M |  Irlanda |
 |
Twist Bioscience Corporation
TWST
|
-16.42 | $ 40.92 | -1.59 % | $ 2.45 B | USA |
 |
Medpace Holdings
MEDP
|
48.98 | $ 581.54 | -1.94 % | $ 18 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
12.85 | $ 185.97 | 1.99 % | $ 20.6 B | USA |
|
Biodesix
BDSX
|
-205.65 | $ 9.61 | -0.57 % | $ 1.25 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Precipio
PRPO
|
-40.56 | $ 24.39 | 0.54 % | $ 31.7 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
9.26 | $ 269.91 | 0.04 % | $ 22.6 B | USA |
 |
Mettler-Toledo International
MTD
|
-680.23 | $ 1 376.67 | -1.16 % | $ 29.2 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 179.26 | -3.57 % | $ 14.8 B | Irlanda |
 |
IDEXX Laboratories
IDXX
|
55.65 | $ 673.4 | -0.49 % | $ 55.5 B | USA |